Back to search
FDAFDA · Food and drugs·Recall number D-0336-2018

Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559

Published February 7, 2018 · Recall initiated: November 20, 2017

Summary

FDA records drug Class II recall D-0336-2018, published February 7, 2018 and initiated November 20, 2017. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Terminated; Reported quantity: 5136 tubes; Lot: Batch Number: 05170598; Exp. 03/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Market complaints related to "gritty texture".

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
Product was distributed throughout the United States.
UPC
3684620192559
Lot
Batch Number: 05170598; Exp. 03/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559 recalled?

Yes. FDA published recall D-0336-2018 on February 7, 2018. Reported hazard: CGMP Deviations: Market complaints related to "gritty texture".

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 3684620192559.